Dr. Jae Park, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Acute Lymphoblastic Leukemia
Studies Leukemia
14 reported clinical trials
27 drugs studied
Area of expertise
1Acute Lymphoblastic Leukemia
CD19 positive
Philadelphia chromosome positive
Philadelphia chromosome negative
2Leukemia
CD19 positive
Philadelphia chromosome negative
Philadelphia chromosome positive
Affiliated Hospitals
Clinical Trials Jae Park, MD is currently running
CAR T Cells
for Acute Lymphoblastic Leukemia
Participants will have a sample of their white blood cells, called T cells, collected using a procedure called leukapheresis. The collected T cells will be sent to a laboratory to be changed (modified) to become 19-28z/IL-18, the CAR T-cell therapy that participants will receive during the study. Making the participants' study therapy will take about 2-4 weeks.
Recruiting1 award Phase 1
ADCLEC.syn1 CAR T-Cell Therapy
for Acute Myeloid Leukemia
The purpose of this study is to test the safety of ADCLEC.syn1 CAR T cells in people with relapsed or refractory AML. The researchers will try to find the highest dose of ADCLEC.syn1 CAR T cells that causes few or mild side effects in participants. Once the researchers find this dose, it will test it in a new group of participants to see if it is effective in treating their relapsed/refractory AML.
Recruiting1 award Phase 1
More about Jae Park, MD
Clinical Trial Related6 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Jae Park, MD has experience with
- Dexamethasone
- Cyclophosphamide
- Dasatinib
- Venetoclax
- Obinutuzumab
- Vemurafenib
Breakdown of trials Jae Park, MD has run
Acute Lymphoblastic Leukemia
Leukemia
Non-Hodgkin's Lymphoma
Chronic Lymphocytic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jae Park, MD specialize in?
Jae Park, MD focuses on Acute Lymphoblastic Leukemia and Leukemia. In particular, much of their work with Acute Lymphoblastic Leukemia has involved CD19 positive patients, or patients who are Philadelphia chromosome positive.
Is Jae Park, MD currently recruiting for clinical trials?
Yes, Jae Park, MD is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Jae Park, MD has studied deeply?
Yes, Jae Park, MD has studied treatments such as Dexamethasone, Cyclophosphamide, Dasatinib.
What is the best way to schedule an appointment with Jae Park, MD?
Apply for one of the trials that Jae Park, MD is conducting.
What is the office address of Jae Park, MD?
The office of Jae Park, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.